30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Cedric Francois

Track

Insider profile

Currently holds a position at Apellis Pharmaceuticals Inc

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
23 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Co-Founder, Director Apellis Pharmaceuticals Inc Jan. 1, 2016 -
President, Chief Executive Officer, Director Apellis Pharmaceuticals Inc Sept. 1, 2009 - Jan. 1, 2016
Cedric Francois's trades of Apellis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-23 2026-01-22
S Sale
54,058 +39.5%
19.99
US$3,241,319 		54,058 +39.5% 19.99 US$3,241,319
2026-01-22 2026-01-22
PrS Proposed sale
18,167
198.74
US$248,739 		18,167 198.74 US$248,739
2026-01-21 2026-01-20
S Sale
86,634 -4.7%
121.41
US$1,428,019 		86,634 -4.7% 121.41 US$1,428,019
2026-01-20 2026-01-20
PrS Proposed sale
8,182
19.79
US$161,946 		8,182 19.79 US$161,946
2026-01-15 2026-01-13
S Sale
10,186 -3.1%
22.19
US$225,999 		10,186 -3.1% 22.19 US$225,999
2026-01-13 2026-01-13
PrS Proposed sale
10,186
22.19
US$225,999 		10,186 22.19 US$225,999
2025-08-29 2025-08-28
S Sale
49,963 -14.0%
28.39
US$1,418,450 		49,963 -14.0% 28.39 US$1,418,450
2025-08-29 2025-08-27
S Sale
175,037 -32.8%
28.19
US$4,934,293 		175,037 -32.8% 28.19 US$4,934,293
2025-08-27 2025-08-27
PrS Proposed sale
225,000
28.72
US$6,462,500 		225,000 28.72 US$6,462,500
2025-07-18 2025-07-17
PlS Planned sale
19,725 -5.6%
20.21
US$398,735 		19,725 -5.6% 20.21 US$398,735
2025-07-17 2025-07-17
PrS Proposed sale
19,725
20.15
US$397,552 		19,725 20.15 US$397,552
2025-07-16 2025-07-15
PlS Planned sale
1,900 -0.6%
20.09
US$38,168 		1,900 -0.6% 20.09 US$38,168
2025-07-15 2025-07-15
PrS Proposed sale
1,900
20.09
US$38,168 		1,900 20.09 US$38,168
2025-07-16 2025-07-14
PlS Planned sale
137,465 -28.6%
20.19
US$2,774,923 		137,465 -28.6% 20.19 US$2,774,923
2025-07-14 2025-07-14
PrS Proposed sale
137,465
20.19
US$2,774,922 		137,465 20.19 US$2,774,922
2025-01-30 2025-01-29
S Sale
2,824 -0.7%
29.52
US$83,375 		2,824 -0.7% 29.52 US$83,375
2025-01-29 2025-01-29
PrS Proposed sale
2,824
29.52
US$83,375 		2,824 29.52 US$83,375
2025-01-23 2025-01-22
S Sale
13,551 -3.1%
30.43
US$412,296 		13,551 -3.1% 30.43 US$412,296
2025-01-22 2025-01-22
PrS Proposed sale
13,551
30.43
US$412,296 		13,551 30.43 US$412,296
2025-01-21 2025-01-17
S Sale
6,007 -2.0%
29.96
US$179,959 		6,007 -2.0% 29.96 US$179,959
2025-01-17 2025-01-17
PrS Proposed sale
6,007
29.96
US$179,959 		6,007 29.96 US$179,959
2025-01-14 2025-01-13
S Sale
6,247 -2.0%
28.70
US$179,302 		6,247 -2.0% 28.70 US$179,302
2025-01-13 2025-01-13
PrS Proposed sale
6,357
28.70
US$182,422 		6,357 28.70 US$182,422
2024-03-05 2024-03-01
S Sale
413 -0.1%
65.68
US$27,126 		413 -0.1% 65.68 US$27,126
2024-03-05 2024-03-01
S Sale
116,512 -27.1%
64.92
US$7,563,528 		116,512 -27.1% 64.92 US$7,563,528
2024-03-05 2024-03-01
S Sale
62,503 -12.7%
64.26
US$4,016,274 		62,503 -12.7% 64.26 US$4,016,274
2024-03-05 2024-03-01
S Sale
41,704 -7.8%
62.96
US$2,625,813 		41,704 -7.8% 62.96 US$2,625,813
2024-03-05 2024-03-01
S Sale
28,868 -5.1%
62.21
US$1,795,965 		28,868 -5.1% 62.21 US$1,795,965
2024-03-01 2024-03-01
PrS Proposed sale
250,000
64.11
US$16,028,714 		250,000 64.11 US$16,028,714
2024-02-13 2024-02-12
S Sale
3,962 -1.2%
67.77
US$268,492 		3,962 -1.2% 67.77 US$268,492
2024-02-12 2024-02-12
PrS Proposed sale
3,962
67.77
US$268,492 		3,962 67.77 US$268,492
2024-01-31 2024-01-29
S Sale
2,843 -0.9%
64.14
US$182,345 		2,843 -0.9% 64.14 US$182,345
2024-01-29 2024-01-29
PrS Proposed sale
2,843
64.14
US$182,345 		2,843 64.14 US$182,345
2024-01-23 2024-01-22
S Sale
13,431 -4.0%
65.00
US$872,961 		13,431 -4.0% 65.00 US$872,961
2024-01-22 2024-01-22
PrS Proposed sale
13,431
65.00
US$872,961 		13,431 65.00 US$872,961
2024-01-17 2024-01-16
S Sale
7,851 -2.3%
66.81
US$524,514 		7,851 -2.3% 66.81 US$524,514
2024-01-16 2024-01-16
PrS Proposed sale
7,851
66.81
US$524,514 		7,851 66.81 US$524,514
2023-11-21 2023-11-21
PrS Proposed sale
5,000
49.00
US$245,000 		5,000 49.00 US$245,000
2023-11-21 2023-11-21
S Sale
5,000 -1.8%
48.80
US$244,000 		5,000 -1.8% 48.80 US$244,000
2023-09-01 2023-09-01
PrS Proposed sale
150,000
41.75
US$6,262,737 		150,000 41.75 US$6,262,737
2023-09-01 2023-09-01
S Sale
10,284 -2.4%
42.44
US$436,453 		10,284 -2.4% 42.44 US$436,453
2023-09-01 2023-09-01
S Sale
139,716 -24.3%
41.70
US$5,826,506 		139,716 -24.3% 41.70 US$5,826,506
2023-05-18 2023-05-16
PlS Planned sale
2,120 -0.8%
87.67
US$185,869 		2,120 -0.8% 87.67 US$185,869
2023-05-18 2023-05-16
PlS Planned sale
7,528 -2.6%
87.02
US$655,059 		7,528 -2.6% 87.02 US$655,059
2023-05-18 2023-05-16
PlS Planned sale
3,007 -1.0%
85.90
US$258,305 		3,007 -1.0% 85.90 US$258,305